Related Experiment Video

Updated: Jun 12, 2026

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans
08:12

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans

Published on: October 5, 2020

The Nrf2-Keap1-ARE signaling pathway: The regulation and dual function of Nrf2 in cancer

Donna D Zhang

    Antioxidants & Redox Signaling
    |May 22, 2010
    PubMed

    Insights

    The transcription factor Nrf2 (NF-E2-related factor-2) is crucial for cellular defense and preventing diseases. However, its role in cancer is complex, as elevated Nrf2 can promote tumor growth and treatment resistance.

    Area of Science:

    • Molecular Biology
    • Cellular Biology
    • Biochemistry

    Background:

    • The NF-E2-related factor-2 (Nrf2) pathway is a critical cellular defense mechanism essential for maintaining homeostasis.
    • Dysregulation of Nrf2 is implicated in various human diseases, including cancer, neurodegenerative disorders, and cardiovascular conditions.

    Discussion:

    • While Nrf2 activation is protective against certain diseases, its overexpression in cancer cells confers resistance to chemotherapy and radiotherapy.
    • Understanding the dual role of Nrf2 in health and disease is vital for developing targeted therapeutic strategies.

    Key Insights:

    • Nrf2 regulates a major cellular defense system, with tight control being essential for cellular balance.
    • The Nrf2-Keap1 pathway's discovery in 1999 has spurred significant research into its biological functions.
    • Identifying Nrf2 modulators offers potential for disease prevention and enhancing cancer treatment efficacy.

    Outlook:

    • Further research into Nrf2 regulation is crucial for its therapeutic applications in disease prevention and cancer therapy.
    • This review provides a comprehensive overview of Nrf2 research, serving as a valuable resource for scientists and students.
    • Continued investigation into the Nrf2-Keap1 pathway will illuminate new avenues for human health interventions.

    Related Concept Videos

    NF-κB-dependent Signaling Pathway02:26

    NF-κB-dependent Signaling Pathway

    The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
    NF-κB-dependent Signaling Mechanism
    The heterodimer of NF-κB...
    MAPK Signaling Cascades01:07

    MAPK Signaling Cascades

    Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
    Interactions Between Signaling Pathways01:19

    Interactions Between Signaling Pathways

    Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
    Convergence and divergence, and cross-talk between signaling pathways
    Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
    mTOR Signaling and Cancer Progression03:03

    mTOR Signaling and Cancer Progression

    The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
    The mTOR pathway or the...
    mTOR Signaling and Cancer Progression03:03

    mTOR Signaling and Cancer Progression

    The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
    The mTOR pathway or the...
    NF-kB-dependent Signaling Pathway02:26

    NF-kB-dependent Signaling Pathway

    The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
    NF-κB-dependent Signaling Mechanism
    The heterodimer of NF-κB...